External shot of Yale

Yale is one of twenty-five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by our Clinical Center Director and Principal Investigator, Kevan Herold, MD, the TrialNet team at Yale is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Our Team

Portrait photo

Kevan Herold, MD

My background and research are in translational immunology. I am interested in understanding the basis for autoimmune diseases and developing new therapies based on our understanding of disease mechanisms. My focus has largely been in the field of autoimmune Type 1 diabetes. The work encompasses basic laboratory work understanding the regulation of autoreactive T cells to clinical trials that involve novel therapeutics. As part of these studies I have also been very interested in analysis of beta cell function in Type 1 diabetes.

Laurie Feldman, MHSA, CCRP

Regional Affiliates

Affiliates provide opportunities for people who do not live near Yale. The affiliate sites listed below work with Yale to offer convenient participation in our research programs.

Joslin Diabetes Center
One Joslin Place Room 316A, Boston, 02215 United States
The Children's Hospital Baystate Med Center
50 Wason Ave , Springfield, 01199 United States
UMass Memorial Medical Center
UMMHC, 55 Lake Ave N , Worcester, United States
Mid-Hudson Medical Group
30 Columbia Street , Poughkeepsie, 12601 United States
Rhode Island Hospital
593 Eddy St , Providence, 02903 United States
ICAHN School of Medicine at Mount Sinai
1 Gustave L. Levy Place Box 1055, New York City, 10029 United States

Research Studies

Long Term Longterm Follow-up

If you are diagnosed with T1D while participating in one of our prevention studies, we’re still here for you. You can continue to receive personal monitoring while helping us learn more. More